| Predicate |
Object |
| contentType |
Comment|Journal Article |
| endingPage |
399 |
| issn |
1743-4262
1743-4254 |
| issueIdentifier |
7 |
| pageRange |
398-399 |
| publicationName |
Nature clinical practice. Oncology |
| startingPage |
398 |
| bibliographicCitation |
Montemurro F, Aglietta M. Does addition of lapatinib to capecitabine improve outcome in women with refractory breast cancer? Nat Clin Pract Oncol. 2007 Jul;4(7):398–9. doi: 10.1038/ncponc0849. PMID: 17549090. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21b135dbd6ca80456ef51d9bb13f42f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb27732caaecaae0f730c65094c95a5e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4231-2291
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2255-7972 |
| date |
2007-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/17549090
https://doi.org/10.1038/ncponc0849 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1743-4254
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32524
https://portal.issn.org/resource/ISSN/1743-4262 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Does addition of lapatinib to capecitabine improve outcome in women with refractory breast cancer? |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 |